Your browser doesn't support javascript.
loading
Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat.
Näveri, L; Strömberg, C; Saavedra, J M.
Afiliação
  • Näveri L; Section on Pharmacology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892.
J Cereb Blood Flow Metab ; 14(6): 1096-9, 1994 Nov.
Article em En | MEDLINE | ID: mdl-7523429
ABSTRACT
The effect of angiotensin (ANG) IV on CBF after experimental subarachnoid hemorrhage (SAH) was studied in rats using laser-Doppler flowmetry. ANG IV (1 microgram/kg/min i.v.) or saline treatments were started 20 min after SAH. ANG IV increased CBF (from 45 to 84% of baseline) by 60 min. In the saline group, CBF remained low (51%). Pretreatment with the specific ANG II antagonist Sar1, Ile8-ANG II did not antagonize ANG IV. Determination of nitric oxide synthase (NOS) activity in vitro or inhibition of NOS in vivo did not support a role for NO in the action of ANG IV.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Hemorragia Subaracnóidea / Angiotensina II / Circulação Cerebrovascular Limite: Animals Idioma: En Revista: J Cereb Blood Flow Metab Ano de publicação: 1994 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Hemorragia Subaracnóidea / Angiotensina II / Circulação Cerebrovascular Limite: Animals Idioma: En Revista: J Cereb Blood Flow Metab Ano de publicação: 1994 Tipo de documento: Article